Clinical Trials Browser

Phase 4 × Carcinoma, Hepatocellular × Nadolol × Clear all

NCT00567216 2010-06-08

GVO-nadolol

Phase 4 Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis